Bempedoic Acid in Patients with Dyslipidemia: A Systematic Review and Meta-Analysis
This systematic review and meta-analysis are conducted to synthesize the efficacy and safety of bempedoic acid in patients requiring lipid-lowering therapy. PubMed, Embase, and Scopus databases were searched for randomized controlled trials from inception till June 2023. The primary outcome was the...
Saved in:
| Main Authors: | Shambo S. Samajdar, Sougata Sarkar, Subhro Chakraborty, Debalina Sarkar, Sourya Ghosh, Sunip Banerjee, Kaushik Biswas, Jyotirmoy Pal, Nandini Chatterjee, Sanjay Bandyopadhyay, Shashank R. Joshi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-05-01
|
| Series: | Medical Journal of Dr. D.Y. Patil Vidyapeeth |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/mjdrdypu.mjdrdypu_576_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Pathogenetic Basis of the Action of Bempedoic Acid
by: A. S. Petrosyan, et al.
Published: (2023-01-01) -
Reshaping Dyslipidaemia Treatment with Bempedoic Acid—A Narrative Review
by: Dominik Strikic, et al.
Published: (2025-06-01) -
Addition of Bempedoic Acid to Statin–Ezetimibe versus Statin Titration in Patients with High Cardiovascular Risk: A Single-Centre Prospective Study
by: Giuseppe Marazzi, et al.
Published: (2024-09-01) -
Bempedoic Acid for Prevention of Cardiovascular Events in People With Obesity: A CLEAR Outcomes Subset Analysis
by: Harold E. Bays, et al.
Published: (2025-02-01) -
Triple Non-Statin Therapy with Ezetimibe, Inclisiran, and Bempedoic Acid in Patients with Genetically Confirmed Statin-Induced Rhabdomyolysis: A Dual Case Report
by: Jozef Dodulík, et al.
Published: (2025-05-01)